Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Identify lessons from common budgeting mistakes to enhance forecasting accuracy and build a stronger, more adaptable financial plan.
27,725 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
GLD's fee drag and tax treatment can erode bullion gains even as gold prices rise. A closer look at cheaper peers and...
A meme-focused token from MemeCore dropped roughly 70%, sending its market cap below $1 billion and triggering renewe...
A high-profile congressman warns that Social Security could face cuts as the trust fund nears insolvency in the early...
A Seattle-based agent is named a 2026 NAR Fair Housing Champion for spearheading a decade-long push to standardize ho...
AVUV has climbed this year, but rate expectations and bank exposure keep its outlook uncertain. Here’s what AVUV inve...
June delivered a sharp pause as the Magnificent Seven shed trillions, signaling a shift toward chipmakers and AI infr...
A Dutch court halted a welfare-detection AI system over privacy and bias concerns, prompting watchdogs to weigh tight...
Alphabet and Amazon posted divergent Q1 2026 results in late April, highlighting the contrast between a high-margin a...
EWY’s 12-month trajectory hinges on two volatile signals: AI memory demand and the concentration risk tied to Samsung...
A record 207 crypto hacks were logged in H1 2026, but total losses fell to $972 million as disruption spreads beyond ...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...